Contact
searchSearch
HMP Global

March 2014 - FRMC

Biotechnology Industry Prospects Remain Strong
03/18/2014
Tim Casey
New York—After several poor years, the biotechnology industry rebounded in 2013 with 45 initial public offerings (IPOs) of biotechnology companies and more money flowing into the sector. It was the most activity since 2000, and the trend has...
New York—After several poor years, the biotechnology industry rebounded in 2013 with 45 initial public offerings (IPOs) of biotechnology companies and more money flowing into the sector. It was the most activity since 2000, and the trend has...
New York—After several poor...
03/18/2014
First Report Managed Care
Optimizing Medication Use and Patient Outcomes
03/18/2014
Tim Casey
Industry professionals must pay attention to optimizing medication use and patient outcomes through better adherence and integrating care delivery.
Industry professionals must pay attention to optimizing medication use and patient outcomes through better adherence and integrating care delivery.
Industry professionals must pay...
03/18/2014
First Report Managed Care
News Connection
ACA Exchange Customers Prefer Cheap, Narrow Network Plans
03/18/2014
Kerri Fitzgerald
A recent poll found that customers who are more likely to sign up for the Patient Protection and Affordable Care Act (ACA) insurance exchanges prefer less costly, narrow networks instead of more expensive, broad network plans. This finding...
A recent poll found that customers who are more likely to sign up for the Patient Protection and Affordable Care Act (ACA) insurance exchanges prefer less costly, narrow networks instead of more expensive, broad network plans. This finding...
A recent poll found that...
03/18/2014
First Report Managed Care
Overuse of EGD Observed in Medicare Patients
03/18/2014
Sarah O'Brien
Esophagogastroduodenoscopy (EGD) has become an effective procedure in evaluating common symptoms, such as abdominal pain and dysphagia.
Esophagogastroduodenoscopy (EGD) has become an effective procedure in evaluating common symptoms, such as abdominal pain and dysphagia.
Esophagogastroduodenoscopy...
03/18/2014
First Report Managed Care
Effect of Practice Nurse Involvement in Depression Management
03/18/2014
Sarah O'Brien
Depression is a health priority in many countries and is the most common mental health disorder, globally.
Depression is a health priority in many countries and is the most common mental health disorder, globally.
Depression is a health priority...
03/18/2014
First Report Managed Care
Effect of Reminder Intervention for Colorectal Cancer Screening
03/18/2014
Kerri Fitzgerald
In a community case study in the Michigan Department of Community Health, researchers found that implementing a reminder system for employees to get screened for colorectal cancer (CRC) resulted in a 16% increase in screening rate. The...
In a community case study in the Michigan Department of Community Health, researchers found that implementing a reminder system for employees to get screened for colorectal cancer (CRC) resulted in a 16% increase in screening rate. The...
In a community case study in the...
03/18/2014
First Report Managed Care
Study Examines Colorectal Cancer Information on the Internet
03/18/2014
Eileen Koutnik-Fotopoulos
The popularity of using the Internet as a source of health information has led to improvements in cancer prevention, particularly among older adults. However, the quality and quantity of health information on the Internet that focuses on...
The popularity of using the Internet as a source of health information has led to improvements in cancer prevention, particularly among older adults. However, the quality and quantity of health information on the Internet that focuses on...
The popularity of using the...
03/18/2014
First Report Managed Care
Monitoring Treatment Response in Colorectal Cancer
03/18/2014
Eileen Koutnik-Fotopoulos
Despite multidisciplinary and multimodality approaches to the management of colorectal cancer (CRC), there is an increasing need to define how clinicians monitor response to novel therapies in this patient population. Monitoring how disease...
Despite multidisciplinary and multimodality approaches to the management of colorectal cancer (CRC), there is an increasing need to define how clinicians monitor response to novel therapies in this patient population. Monitoring how disease...
Despite multidisciplinary and...
03/18/2014
First Report Managed Care
HER2 Testing in Breast Cancer: ASCO/CAP Updated Guidelines
03/18/2014
Mary Beth Nierengarten
The 2013 updated American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines provide oncologists and pathologists with a number of key recommendations for testing the status of human epidermal growth factor...
The 2013 updated American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines provide oncologists and pathologists with a number of key recommendations for testing the status of human epidermal growth factor...
The 2013 updated American...
03/18/2014
First Report Managed Care
Dolutegravir a Promising Treatment Option for HIV
03/18/2014
Mary Mihalovic
Dolutegravir, used with abacavir and lamivudine, showed more efficacy and a better safety profile in the treatment of HIV-1 infection compared with EFV-TDF-FTC.
Dolutegravir, used with abacavir and lamivudine, showed more efficacy and a better safety profile in the treatment of HIV-1 infection compared with EFV-TDF-FTC.
Dolutegravir, used with abacavir...
03/18/2014
First Report Managed Care
News Connection
Bapineuzumab Shows No Clinical Benefit for Mild-to-Moderate AD
03/18/2014
Mary Beth Nierengarten
Results of 2 phase 3, multicenter, randomized, double-blind trials show no clinical benefit of bapineuzumab to treat patients with mild-to-moderate Alzheimer’s disease (AD) [N Engl J Med. 2014;370:322-33].   The study did find, however, that...
Results of 2 phase 3, multicenter, randomized, double-blind trials show no clinical benefit of bapineuzumab to treat patients with mild-to-moderate Alzheimer’s disease (AD) [N Engl J Med. 2014;370:322-33].   The study did find, however, that...
Results of 2 phase 3,...
03/18/2014
First Report Managed Care
Standard Laboratory Test Aids in Predicting the Success of SIRT
03/18/2014
Sarah O'Brien
The results of the recently released MORE (Metastatic Colorectal Cancer Liver Metastases Outcomes after Radio Embolization) study found standard laboratory tests have been confirmed as a means of predicting patient outcomes prior to selective...
The results of the recently released MORE (Metastatic Colorectal Cancer Liver Metastases Outcomes after Radio Embolization) study found standard laboratory tests have been confirmed as a means of predicting patient outcomes prior to selective...
The results of the recently...
03/18/2014
First Report Managed Care
News Connection
Solanezumab Shows No Efficacy in Improving Cognition or Functional Ability for Mild-to-Moderate AD
03/18/2014
Mary Beth Nierengarten
Results of two phase 2, randomized, double-blind trials showed that solanezumab does not improve cognition or functional ability in patients with mild-to-moderate Alzheimer’s disease (AD) [N Engl J Med. 2014;370:311-321].
Results of two phase 2, randomized, double-blind trials showed that solanezumab does not improve cognition or functional ability in patients with mild-to-moderate Alzheimer’s disease (AD) [N Engl J Med. 2014;370:311-321].
Results of two phase 2,...
03/18/2014
First Report Managed Care
CSS to Increase CMS Acute MI Core Measure Compliance
03/18/2014
Mary Mihalovic
The computerized clinical surveillance system (CSS), known as TheraDoc, is used to increase Centers for Medicare & Medicaid Services (CMS) core measure compliance among patients with acute myocardial infarction (MI). CSS was recently studied...
The computerized clinical surveillance system (CSS), known as TheraDoc, is used to increase Centers for Medicare & Medicaid Services (CMS) core measure compliance among patients with acute myocardial infarction (MI). CSS was recently studied...
The computerized clinical...
03/18/2014
First Report Managed Care
Managed Care Q&A
Health Exchanges, ACA, and Recent Drug Approvals Changing the Landscape - Q & A with Gary Owens, MD, President, Gary Owens Associates
03/18/2014
First Report Managed Care conducted an interview with Gary Owens, MD, one of our Editorial Advisory Board members, to discuss the changing climate of benefit management and drug approvals under the Patient Protection and Affordable Care Act...
First Report Managed Care conducted an interview with Gary Owens, MD, one of our Editorial Advisory Board members, to discuss the changing climate of benefit management and drug approvals under the Patient Protection and Affordable Care Act...
First Report Managed Care...
03/18/2014
First Report Managed Care
The Internet Leads to Greater Patient Participation and Self-Management
03/18/2014
Mary Mihalovic
The use of asynchronous, or nonconcurrent, Internet-based communication in healthcare is likely an important tool to increase patient participation and self-management, according to results of a recent literature review [J Med Internet Res....
The use of asynchronous, or nonconcurrent, Internet-based communication in healthcare is likely an important tool to increase patient participation and self-management, according to results of a recent literature review [J Med Internet Res....
The use of asynchronous, or...
03/18/2014
First Report Managed Care
Walmart Expands into Health Insurance Exchanges
03/18/2014
Tim Casey
Las Vegas—Since Walmart introduced its $4 program for generic drugs and over-the-counter medications in 2006, the largest retail company in the United States has become a major figure in healthcare. The company is now hoping to expand,...
Las Vegas—Since Walmart introduced its $4 program for generic drugs and over-the-counter medications in 2006, the largest retail company in the United States has become a major figure in healthcare. The company is now hoping to expand,...
Las Vegas—Since Walmart...
03/18/2014
First Report Managed Care
Conference Insider
Pharmaceutical Companies and Reimbursement Issues for New Drugs
03/18/2014
Tim Casey
New York—When GlycoMimetics, Inc., developed its program for a promising new drug, the biotechnology company considered not only the medication’s safety and efficacy but also its economic value. Other pharmaceutical manufacturers are...
New York—When GlycoMimetics, Inc., developed its program for a promising new drug, the biotechnology company considered not only the medication’s safety and efficacy but also its economic value. Other pharmaceutical manufacturers are...
New York—When GlycoMimetics,...
03/18/2014
First Report Managed Care

Behind the Bill

Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care
BEHIND THE BILL
When Agencies Lose Power: How 3 Seismic Shifts are Transforming Pharmaceutical Regulation
05/07/2025
Katie Hayes, MJ
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months,...
05/07/2025
First Report Managed Care
Behind the Bill
The Medicare Paradox, Part 3: Strategic Trade Doesn’t Have to be a Zero-Sum Game
05/07/2025
Katie Hayes, MJ
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve...
05/07/2025
First Report Managed Care

Trending Articles

News
Comparative Effectiveness for Bronchodilator Responsiveness Testing
02/09/2024
Emry Lloyd
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the...
02/09/2024
First Report Managed Care
News
Trial to Test CAR T-Cell Therapy for Refractory Progressive MS
03/18/2024
Jolynn Tumolo
An autologous, fully human CD19 chimeric antigen receptor (CAR) T-cell product candidate recently received clearance from the US Food and Drug Administration (FDA) as an investigational new drug for the treatment of patients with refractory...
An autologous, fully human CD19 chimeric antigen receptor (CAR) T-cell product candidate recently received clearance from the US Food and Drug Administration (FDA) as an investigational new drug for the treatment of patients with refractory...
An autologous, fully human CD19...
03/18/2024
First Report Managed Care
Conference Coverage
PBM Legislation: Navigating Congressional Delays and Encouraging Progress
04/17/2024
Hannah Musick
Explore the world of federal pharmacy benefit manager (PBM) legislation and its potential impact on stakeholders in this in-depth analysis presented by Ross Margulies, JD, MPH, Partner and Co-Chair Healthcare and Life Sciences Coverage &...
Explore the world of federal pharmacy benefit manager (PBM) legislation and its potential impact on stakeholders in this in-depth analysis presented by Ross Margulies, JD, MPH, Partner and Co-Chair Healthcare and Life Sciences Coverage &...
Explore the world of federal...
04/17/2024
First Report Managed Care
Conference Coverage
The Impact of Fatigue on Prospective Memory in Persons With MS
05/23/2024
Hannah Musick
High fatigue levels in persons with multiple sclerosis (MS) are significantly associated with subjective impairment in prospective memory, particularly in tasks such as forgetting the date and missing appointments.
High fatigue levels in persons with multiple sclerosis (MS) are significantly associated with subjective impairment in prospective memory, particularly in tasks such as forgetting the date and missing appointments.
High fatigue levels in persons...
05/23/2024
First Report Managed Care
Interview
Enhancing Patient Services: Payer and Provider Considerations
06/28/2024
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support...
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support...
Patient services emerged as a...
06/28/2024
First Report Managed Care

March 2014 Volume 11 Issue 3

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use